close
Home
#WE-WONT-REST
chevron_right
News & Events
chevron_right
About medicines
chevron_right
More Than Medicine
chevron_right
Pharmaceutical Legislation
Relationships & code
chevron_right
Publications
chevron_right
About us
chevron_right
Contact us
KMS Login
arrow_back
close
#WE-WONT-REST
The impact of innovation
expand_more
expand_less
chevron_right
Anti-amyloid therapies to treat Alzheimer’s Disease
Car-T therapies
Combination therapies for lung cancer
Anti-viral therapies for Hepatitis B and HIV
Gene therapies for rare diseases
mRNA vaccines for brain cancer
Remyelinating therapies for e.g. Multiple sclerosis
NASH treatments
Patient stories
expand_more
expand_less
chevron_right
Alzheimer's patient story
Blood cancer patient story
Lung cancer patient story
Haemophilia patient story
Members updates
Illness Never Sleeps
Brighter Tomorrow
For the Chance
Questions Inspire Solutions
News & Events
The EFPIA View
Events
Newsletter
About medicines
Development of medicines
expand_more
expand_less
chevron_right
Animal Use and Welfare
Antimicrobial resistance (AMR)
Digital Health
Intellectual Property
Precision medicine
Public-private partnerships
Regulations, safety & supply
SMEs in Europe
Trade
Unmet medical need
Use of medicines
expand_more
expand_less
chevron_right
HTA & Relative Efficacy Assessment
Disease-specific groups
Healthcare Systems
Value of medicines
Access to medicines
expand_more
expand_less
chevron_right
Back Innovation, Boost Access
More Than Medicine
Improving Health
Turning science into new medicines
Responsible Innovation
Economic impact
Pharmaceutical Legislation
Relationships & code
The EFPIA Code
Patient organisations
Healthcare professionals (HCPs)
Disclosure of payments
National codes
EU institutions
Publications
Data center
Downloads
Cancer Comparator Report
expand_more
expand_less
chevron_right
About
Recommendations
Cancer Cases
Cancer Deaths
Survival
Cancer Care
Cancer Types
Resources
About us
Who we are
EFPIA Japan
Membership
Job vacancies
Contact us
arrow_back
close
The impact of innovation
Anti-amyloid therapies to treat Alzheimer’s Disease
Car-T therapies
Combination therapies for lung cancer
Anti-viral therapies for Hepatitis B and HIV
Gene therapies for rare diseases
mRNA vaccines for brain cancer
Remyelinating therapies for e.g. Multiple sclerosis
NASH treatments
Development of medicines
Animal Use and Welfare
Antimicrobial resistance (AMR)
Digital Health
Intellectual Property
Precision medicine
Public-private partnerships
Regulations, safety & supply
SMEs in Europe
Trade
Unmet medical need
Use of medicines
HTA & Relative Efficacy Assessment
Disease-specific groups
Healthcare Systems
Value of medicines
Access to medicines
Back Innovation, Boost Access
Cancer Comparator Report
About
Recommendations
Cancer Cases
Cancer Deaths
Survival
Cancer Care
Cancer Types
Resources
WeWontRest
Patient stories
Patient stories
close
Patient stories
Filter by
Disease area
Access
Alzheimer's
AMR
Arthritis
Asthma
Atopic Dermatitis
Blood cancer
Cardiovascular
Clinical trials
Collaboration
Crohn's disease
Diabetes
eHealth
General
Haemophilia
Hepatitis C
HIV
Innovation
Lung cancer
Migraine
Multiple Sclerosis
Oncology
Osteoporosis
Outcomes
Parkinson's
Patients
Patient Engagement
Pediatrics
Rare Diseases
Vaccines
Cardiovascular disease
Clear filters
Juan
Alzheimer's caregiver
For the chance of my mother remembering her childhood home in the mountains
Read more
Load more
Back to top
close
continue